CARE Ratings Ltd is an India-based company credit rating firm. The company's operating segment includes Ratings and related services and Others. It generates maximum revenue from the Ratings and related services segment. The company provides ratings for the Corporate Sector; Financial Sector; Structured Finance; Insurance Sector; Infrastructure Sector and others.
1993
563
LTM Revenue $38.6M
LTM EBITDA n/a
$318M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CARE Ratings has a last 12-month revenue of $38.6M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, CARE Ratings achieved revenue of $38.5M and an EBITDA of $18.4M.
CARE Ratings expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See CARE Ratings valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $32.4M | $38.5M | XXX | XXX | XXX |
Gross Profit | $15.7M | $18.0M | XXX | XXX | XXX |
Gross Margin | 48% | 47% | XXX | XXX | XXX |
EBITDA | $15.9M | $18.4M | XXX | XXX | XXX |
EBITDA Margin | 49% | 48% | XXX | XXX | XXX |
Net Profit | $8.7M | $9.7M | XXX | XXX | XXX |
Net Margin | 27% | 25% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, CARE Ratings's stock price is INR 1124 (or $13).
CARE Ratings has current market cap of INR 33.6B (or $391M), and EV of INR 27.4B (or $318M).
See CARE Ratings trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$318M | $391M | XXX | XXX | XXX | XXX | $0.51 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, CARE Ratings has market cap of $391M and EV of $318M.
CARE Ratings's trades at 8.2x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate CARE Ratings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for CARE Ratings and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $318M | XXX | XXX | XXX |
EV/Revenue | 8.3x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | 27.6x | XXX | XXX | XXX |
P/E/Growth | 1.4x | XXX | XXX | XXX |
EV/FCF | 22.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCARE Ratings's NTM/LTM revenue growth is 14%
CARE Ratings's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $16K for the same period.
Over next 12 months, CARE Ratings's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate CARE Ratings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for CARE Ratings and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 19% | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $16K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 24% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Wolters Kluwer | XXX | XXX | XXX | XXX | XXX | XXX |
Gumtree Australia | XXX | XXX | XXX | XXX | XXX | XXX |
Gumtree Australia | XXX | XXX | XXX | XXX | XXX | XXX |
Stock3 | XXX | XXX | XXX | XXX | XXX | XXX |
Business Online | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CARE Ratings acquired XXX companies to date.
Last acquisition by CARE Ratings was XXXXXXXX, XXXXX XXXXX XXXXXX . CARE Ratings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was CARE Ratings founded? | CARE Ratings was founded in 1993. |
Where is CARE Ratings headquartered? | CARE Ratings is headquartered in India. |
How many employees does CARE Ratings have? | As of today, CARE Ratings has 563 employees. |
Who is the CEO of CARE Ratings? | CARE Ratings's CEO is Mr. Mehul Harshadray Pandya. |
Is CARE Ratings publicy listed? | Yes, CARE Ratings is a public company listed on NSE. |
What is the stock symbol of CARE Ratings? | CARE Ratings trades under CARERATING ticker. |
When did CARE Ratings go public? | CARE Ratings went public in 2012. |
Who are competitors of CARE Ratings? | Similar companies to CARE Ratings include e.g. Wolters Kluwer, Gumtree Australia, Gumtree Australia, Stock3. |
What is the current market cap of CARE Ratings? | CARE Ratings's current market cap is $391M |
What is the current revenue of CARE Ratings? | CARE Ratings's last 12-month revenue is $38.6M. |
What is the current EV/Revenue multiple of CARE Ratings? | Current revenue multiple of CARE Ratings is 8.2x. |
What is the current revenue growth of CARE Ratings? | CARE Ratings revenue growth between 2023 and 2024 was 19%. |
Is CARE Ratings profitable? | Yes, CARE Ratings is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.